Acura Pharmaceuticals (OTCMKTS:ACUR) Stock Passes Below 200-Day Moving Average of $0.56

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.56 and traded as low as $0.50. Acura Pharmaceuticals shares last traded at $0.54, with a volume of 7,633 shares trading hands.

The company has a market capitalization of $35.15 million, a PE ratio of -18.00 and a beta of 0.59. The company’s 50 day moving average is $0.53 and its two-hundred day moving average is $0.56. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 1.97.

Acura Pharmaceuticals Company Profile (OTCMKTS:ACUR)

Acura Pharmaceuticals, Inc is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.

Featured Article: What is the Hang Seng index?  

Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.